JACC: Case Reports (Apr 2020)

Percutaneous Transcatheter Valve-in-Valve Pulmonary and Tricuspid Replacement in Carcinoid Heart Disease

  • Suvitesh Luthra, MD,
  • Carlo Olevano, MD,
  • Trevor Richens, MD,
  • Geoff M. Tsang, MD

Journal volume & issue
Vol. 2, no. 4
pp. 533 – 536

Abstract

Read online

Surgical valve replacement is the most effective treatment for carcinoid heart disease; however, reoperation for prosthetic valve failure is burdened by high risk. We report the first described percutaneous transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration for any reason in a patient with carcinoid heart disease. (Level of Difficulty: Advanced.)

Keywords